Cannabis Science of COLORADO SPRINGS, Colo., announced a plan for testing an emerging cannabis based medicines for Veterans who suffer from Post Traumatic Stress Disorder (PTSD).
Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., stated, "Times are changing. There is an ever-increasing demand for our cannabis-based drugs, and this demand is growing exponentially throughout the United States and the rest of the world. Modern science supports the public demand for cannabis-based FDA approved drug products that reduce the impact of critical life altering illnesses. The public need for our products drives our efforts to rapidly move our drugs through all available regulatory channels. We believe this enormous public demand on a global scale is a major key to our success and we are very excited to be positioned to provide solutions."
The Company has designed a program to test the efficacy of their cannabis extract-based oral medicine to provide immediate relief of the negative consequences of PTSD in military veterans. Dr. Mitch Earleywine (State University of New York (SUNY Albany, SAB) the first member of the Cannabis Science Scientific Advisory Board, will conduct a Veterans survey regarding the use of medical marijuana for PTSD.
Cannabis Science is developing an online progress chart that will be available at the www.cannabisscience.com website in the near future. This online tracking initiative will allow the general public immediate access to monitor each stage of development, submit questions, and request special circumstance information as we take our cannabis-based drugs to market.
The Company has designed a program to test the efficacy of their cannabis extract-based oral medicine to provide immediate relief of the negative consequences of PTSD in military veterans. Dr. Mitch Earleywine (State University of New York (SUNY Albany, SAB) the first member of the Cannabis Science Scientific Advisory Board, will conduct a Veterans survey regarding the use of medical marijuana for PTSD.
Cannabis Science is developing an online progress chart that will be available at the www.cannabisscience.com website in the near future. This online tracking initiative will allow the general public immediate access to monitor each stage of development, submit questions, and request special circumstance information as we take our cannabis-based drugs to market.